Sourav Ganguly becomes the brand Ambassador for Piramal's antacid Polycrol

Mumbai: Piramal Enterprises' Consumer Products Division has announced its association with Sourav Ganguly, Former Captain of the Indian Cricket Team & Current President, Board of Control for Cricket in India (BCCI) as the brand ambassador for 'Polyrol', its antacid brand.

Polycrol, a legacy brand over 4 decades, has established itself as a trusted product amongst consumers by providing them with quick relief from acidity. Available in a mint flavour, Polycrol is one of India's leading liquid antacid brands, and is amongst the top 3 in Eastern India, including West Bengal, Assam and Odisha.

Commenting on this association, Nandini Piramal, Executive Director, Piramal Enterprises Limited said, "We are pleased to have Sourav Ganguly as the brand ambassador of Polycrol. Sourav, fondly known as 'Maharaja' in Eastern India, has been one of the world's leading batsmen and a successful captain of the Indian cricket team. His association with Polycrol is a testament to our legacy brand's strength and trustworthiness."

Sourav Ganguly, Former Captain of the Indian Cricket Team & Current President, BCCI said, "Polycrol has been a household name in the East and has been a part of my family too, for many years now. We love our food and hence are always ready with Polycrol. I feel honoured to be associated with such a credible brand and look forward to creating new success benchmarks."

The Piramal Group, led by Ajay Piramal, is one of India's leading business conglomerates with a global footprint. With operations in 30 countries and brand presence in over 100 countries, the Group's turnover is ~$2.2 billion in FY2019.

The Group's diversified portfolio includes a presence in industries like healthcare, financial services, glass packaging and real estate.

Driven by its core values, the Group steadfastly pursues inclusive growth, while adhering to ethical and value-driven practices. Piramal Foundation (a Section 8 Company), the Group's philanthropic arm, has initiatives in primary healthcare and nutrition, water, education leadership and women empowerment across 25 states of India.

In Pharma, through end-to-end manufacturing capabilities across 13 global facilities and a large global distribution network to over 100 countries, PEL sells a portfolio of niche differentiated pharma products and provides an entire pool of pharma services (including in the areas of injectable, HPAPI etc.). The Company is also strengthening its presence in the Consumer Product segment in India.

Read also: Piramal Group to infuse Rs 500 crore in pharma operations in Telangana